Lobaplatin inhibits growth of gastric cancer cells by inducing apoptosis. 2014

Chu-Yang Yin, and Xiao-Lin Lin, and Lei Tian, and Ming Ye, and Xin-Ying Yang, and Xiu-Ying Xiao
Chu-Yang Yin, Department of Breast Surgery, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China.

OBJECTIVE To assess the anti-cancer effect of lobaplatin on human gastric cancer cells, and to explore the underlying molecular mechanisms. METHODS The human gastric cancer cell lines MKN-28, AGS and MKN-45 were used. The cytotoxicity of lobaplatin was detected using an MTS cell proliferation assay. Flow cytometry was used to detect cell apoptosis using Annexin V-FITC Apoptosis Detection Kit. The expression of apoptosis-regulated genes was examined at the protein level using Western blot. RESULTS Lobaplatin inhibited the proliferation of human gastric cancer cells and induced apoptosis, which may be associated with the up-regulation of Bax expression, poly(ADP-ribose) polymerase (PARP) cleavage, p53 expression and the reduction of Bcl-2 expression. CONCLUSIONS The cytotoxicity of lobaplatin may be due to its ability of inducing apoptosis of gastric cancer cells, which would support the potential use of lobaplatin for the therapy of gastric cancer.

UI MeSH Term Description Entries
D009944 Organoplatinum Compounds Organic compounds which contain platinum as an integral part of the molecule. Compounds, Organoplatinum
D003503 Cyclobutanes Four carbon cycloparaffin cyclobutane (the structural formula (CH2)4) and its derivatives.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Chu-Yang Yin, and Xiao-Lin Lin, and Lei Tian, and Ming Ye, and Xin-Ying Yang, and Xiu-Ying Xiao
January 2023, Combinatorial chemistry & high throughput screening,
Chu-Yang Yin, and Xiao-Lin Lin, and Lei Tian, and Ming Ye, and Xin-Ying Yang, and Xiu-Ying Xiao
March 2011, Cancer letters,
Chu-Yang Yin, and Xiao-Lin Lin, and Lei Tian, and Ming Ye, and Xin-Ying Yang, and Xiu-Ying Xiao
January 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Chu-Yang Yin, and Xiao-Lin Lin, and Lei Tian, and Ming Ye, and Xin-Ying Yang, and Xiu-Ying Xiao
January 2013, Cancer biotherapy & radiopharmaceuticals,
Chu-Yang Yin, and Xiao-Lin Lin, and Lei Tian, and Ming Ye, and Xin-Ying Yang, and Xiu-Ying Xiao
March 1998, Methods and findings in experimental and clinical pharmacology,
Chu-Yang Yin, and Xiao-Lin Lin, and Lei Tian, and Ming Ye, and Xin-Ying Yang, and Xiu-Ying Xiao
March 2013, Planta medica,
Chu-Yang Yin, and Xiao-Lin Lin, and Lei Tian, and Ming Ye, and Xin-Ying Yang, and Xiu-Ying Xiao
January 2020, Nutrition and cancer,
Chu-Yang Yin, and Xiao-Lin Lin, and Lei Tian, and Ming Ye, and Xin-Ying Yang, and Xiu-Ying Xiao
November 2018, Phytotherapy research : PTR,
Chu-Yang Yin, and Xiao-Lin Lin, and Lei Tian, and Ming Ye, and Xin-Ying Yang, and Xiu-Ying Xiao
January 2020, Cancer management and research,
Chu-Yang Yin, and Xiao-Lin Lin, and Lei Tian, and Ming Ye, and Xin-Ying Yang, and Xiu-Ying Xiao
January 2016, Journal of Cancer,
Copied contents to your clipboard!